Heparanase expression in invasive trophoblasts and acute vascular damage

Glycobiology

Volumn 10, Issue 5, 2000, Pages 467-475

  Dempsey, Laurie A ^a   Plummer, Timothy B ^a   Coombes, Sarah L ^a   Platt, Jeffrey L ^a,b,c  

^a Department of Surgery ^*  (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Heparan sulfate; Heparanase; Hyperacute rejection; Placenta; Xenografts

Indexed keywords

COMPLEMENTARY DNA; HEPARAN SULFATE; HEPARANASE; MONOCLONAL ANTIBODY;

ARTERY WALL; ARTICLE; BLOOD VESSEL INJURY; CELL INVASION; CHROMOSOME 4Q; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE ISOLATION; GENE MAPPING; GRAFT REJECTION; HUMAN; HUMAN CELL; INFLAMMATION; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TROPHOBLAST;

MAMMALIA;

EID: 0034050073     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/10.5.467     Document Type: Article

References (55)

1. Altschul, S.F., Gish, W., Miller, W., Myers, E.W. and Lipman, D.J. (1990) Basic local alignment search tool. J. Mol. Biol., 215, 403-410.
2. Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M.T., Spring, J., Gallo, R.L. and Lose, E.J. (1992) Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell. Biol., 8, 365-393.
3. Brunner, G., Garilove, J., Rifkin, D.B. and Wilson, E.L. (1991) Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan. J. Cell Biol., 114, 1275-1283.
4. Cardin, A.D. and Weintraub, H.J. (1989) Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis, 9, 21-32.
5. Carson, D.D., DeSouza, M.M. and Regisford, E.G.C. (1998) Mucin and proteoglycan functions in embryo implantation. Bioessays, 20, 577-583.
6. Cross, J.C., Werb, Z. and Fisher, S.J. (1994) Implantation and the placenta: key pieces of the development puzzle. Science, 266, 1508-1518.
7. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
8. Daniels, L.J. and Platt, J.L. (1997) Hyperacute xenograft rejection as an immunologic barrier to xenotransplantation. Kidney Int., 51, S28-S35.
9. Freeman, C. and Parish, C.R. (1998) Human platelet heparanase: purification, characterization and catalytic activity. Biochem., J., 330, 1341-1350.
10. Fridman, R., Lider, O., Naparstek, Y., Fuks, Z., Vlodavsky, I. and Cohcn, I.R. (1987) Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix. J. Cell Physiol., 130, 85-92.
11. Fugman, D.A., Witte, D.P., Jones, C.L.A., Aronow, B.J. and Lieberman, M.A. (1990) In vitro establishment and characterization of a human megakaryoblastic cell line. Blood, 75, 1252-1261.
12. Galfré, G. and Milstein, C. (1981) Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol. 73, 3-46.
13. Gilat, D., Hershkoviz, R., Goldkorn, I., Cahalon, L., Korner, G., Vlodavsky, I. and Lider, O. (1995) Molecular behavior adapts to context: heparanase functions as an extracellular matrix-degrading enzyme or as a T-cell adhesion molecule, depending on the local pH. J. Exp. Med., 181, 1929-1934.
14. Gonzalez-Stawinski, G.V., Parker, W., Holzknecht, Z.E., Huber, N.S. and Platt, J.L. (1999) Partial sequence of human platelet heparitinase and evidence of its ability to polymerize. Biochim. Biophys. Acta, 1429, 431-438.
15. Goshen, R., Hochberg, A.A., Korner, G., Levy, E., Ishai-Michaeli, R., Elkin, M., de Groot, N. and Vlodavsky, I. (1996) Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts. Mol. Human Reproduction, 2, 679-684.
16. Graham, L.D. and Underwood, P.A. (1996) Comparison of the heparanase enzymes from mouse melanoma cells, mouse macrophages and human platelets. Biochemistry Mol. Biol. Int., 39, 536-571.
17. Hileman, R.E., Fromm, J.R., Weiler, J.M. and Linhardt, R.J. (1998) Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays, 20, 156-167.
18. Hoogewerf, A.J., Leone, J.W., Reardon, I.M, Howe, W.J., Asa, D., Heinrikson, R.L. and Ledbetter, S.R. (1995) CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/ heparan sulfate-degrading enzymes. J. Biol. Chem., 270, 3268-3277.
19. Hulett, M.D., Freeman, C., Hamdorf, B.J., Baker, R.T., Harris, M.J. and Parish, C.R. (1999) Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nature Med., 5, 803-809.
20. Ihrcke, N.S. and Platt, J.L. (1996) Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell surface molecules. J. Cell Physiol., 168, 625-637.
21. Ihrcke, N.S., Parker, W., Reissner, K.J. and Platt, J.L. (1998) Regulation of platelet heparanase during inflammation: role of pH and proteinases. J. Cell Physiol. 175, 255-267.
22. Ihrcke, N.S., Wrenshall, L.E., Lindman, B.J. and Platt, J.L. (1993) Role of heparan sulfate in immune system-blood vessel interactions. Immunol. Today, 14, 500-505.
23. Ioannou, P., Amemiya, C., Garnes, J., Kroisel, P., Shizuya, H., Chen, C., Batzer, M. and de Jong, P. (1994) A new bacteriophage Pl-derived vector for the propagation of large human DNA fragments. Nature Genet., 6, 84-89.
24. Ishai-Michaeli, R., Eldor, A. and Vlodavsky, I. (1990) Heparanase activity expressed by platelets, neutrophils and lymphoma cells releases active fibroblast growth factor from the extracellular matrix. Cell Reg., 1, 833-842.
25. Kim, C.H. and Broxmeyer, H.E. (1999) Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J. Leukocyte Biol., 65, 6-15.
26. Kjellen, L. and Lindahl, U. (1991) Proteoglycans: structures and interactions. Annu. Rev. Biochem., 60, 443-475.
27. Kyte, J. and Doolittle, R.F. (1982) A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105-132.
28. Lennon, G., Auffray, C., Polymeropoulos, M. and Soares, M.B. (1996) the I.M.A.G.E. consortium: an integrated nuclear analysis of genomes and their expression. Genomics, 33, 151-152.
29. Lindahl, U., Kusche-Gullberg, M. and Kjellén, L. (1998) Regulated diversity of heparan sulfate. J. Biol. Chem., 273, 24979-24982.
30. Liu, S., Zhou, F., Höök, M. and Carson, D.D. (1997) A heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities. Proc. Natl. Acad. Sci. USA, 94, 1739-1744.
31. Marcheiti, D., Liu, S., Spohn, W.C. and Carson, D.D. (1997) Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate. J. Biol. Chem., 272, 15891-15897.
32. Matzner, Y., Bar-Ner, M., Yahalom, J., Ishai-Michaeli, R., Fuks, Z. and Vlodavsky, I. (1985) Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils: possible role in invasion through basement membranes. J. Clin. Invest., 76, 1306-1313.
33. Nakajima, M., Di Ferrante, D., Irimura, T., Di Ferrante, N. and Nicolson, G.L. (1983) Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science, 220, 611-612.
34. Nakajima, M., Irimura, T. and Nicolson, G.L. (1988) Heparanases and tumor metastasis. J. Cell Biochem., 36, 157-167.
35. Naparstek, Y., Cohen, I.R., Fuks, Z. and Vlodavsky, I. (1984) Activated T-lymphocytes produce a matrix-degrading heparan sulfate endoglycosidase. Nature, 310, 241-244.
36. Oosta, G.M., Favreau, L.V., Beeler, D.L. and Rosenberg, R.D. (1982) Purification and properties of human platelet heparitinase. J. Biol. Chem., 257, 11249-11255.
37. Platt, J.L. (1996) The immunological barriers to xenotransplantation. Crit. Rev. Immunol., 16, 331-358.
38. Platt, J.L. (1997) Hyperacute xenograft rejection. In Cooper, D.K.C., (ed.), Xenotransplantation. Springer-Verlag, Heidelberg.
39. Platt, J.L., Trescony, P., Lindman, B.J. and Oegema, T.R. (1990a) Heparin and heparan sulfate delimit nephron formation in fetal metanephric kidneys. Dev. Biol., 139, 338-348.
40. Platt, J.L., Vercellotti, G.M., Lindman, B.J., Oegema, T.R. Jr., Bach, F.H. and Dalmasso, A.P. (1990b) Release of heparan sulfate from endothelial cells: Implications for the pathogenesis of hyperacute rejection. J. Exp. Med.. 171, 1363-1368.
41. Rosenberg, R.D., Shworak, N.W., Liu, J., Schwartz, J.J. and Zhang, L. (1997) Heparan sulfate proteoglycans of the cardiovascular system. J. Clin. Invest., 99, 2062-2070.
42. Salmivirta, M., Lidholt, K. and Lindahl, U. (1996) Heparan sulfate: a piece of information. FASEB J., 10, 1270-1279.
43. Sandback Pikas, D., Li, J.-p., Vlodavsky, I. and Lindahl, U. (1998) Substrate specificity of heparanases from human hepatoma and platelets. J. Biol. Chem., 273, 18770-18777.
44. Shimada, K. and Ozawa, T. (1987) Subendothelial extracellular-matrix heparan sulfate proteoglycan-degrading activity of human monocyte macrophages. Heart Vessels, 3, 175-181.
45. Stevens, R.B., Wang, Y.L., Kaji, H., Lloveras, J.. Dalmasso, A.B., Bach, F.H., Rubinstein, P., Sutherland, D.E.R. and Platt, J.L. (1993) Administration of nonanticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival. Transplant Proc., 25, 382.
46. Stringer, S.E. and Gallagher, J.T. (1997) Heparan sulphate. Int. J. Biochem. Cell Biol., 29, 709-714.
47. Villanueva, G.B., Nakajima, M. and Nicolson, G.L. (1989) Heparin derivatives as inhibitors of heparanase from metastatic melanoma cells. Ann. N.Y. Acad. Sci., 556, 496-498.
48. Vlodavsky, I., Eldor, A., Bar-Ner, M., Friedman, R., Cohen, I.R. and Klagsbrun, M. (1988) Heparan sulfate degradation in tumor cell invasion and angiogenesis. Adv. Exp. Med. Biol., 233, 201-210.
49. Vlodavsky, I., Eldor, A., Haimovitz-Friedman, A., Ishai-Michaeli, R., Lider, O., Naparstek, Y., Cohen, I.R. and Fuks, Z. (1992) Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis, 12, 112-127.
50. Vlodavsky, I., Friedman, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., Spector, L. and Pecker, I. (1999) Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nature Med., 5, 793-802.
51. Weiss, L., Orr, F.W. and Honn, K.V. (1988) Interactions of cancer cells with the microvasculature during metastasis. FASEB J., 2, 12-21.
52. Wrenshall, L.E., Cerra, F.B., Carlson, A., Bach, F.H. and Platt, J.L. (1991) Regulation of T lymphocyte responses by heparan sulfate. J. Immunol., 147, 455-459.
53. Wrenshall, L.E., Carlson, A., Cerra, F.B. and Platt, J.L. (1994) Modulation of cytolytic T-cell responses by heparan sulfate. Transplantation, 57, 1087-1094.
54. Yanagishita, M. (1992) Glycosylphosphatidylinositol-anchored and core protein intercalated heparan sulfate proteoglycans in rat ovarian granulosa cell have distinct secretory, endocytic and intracellular degradative pathways. J. Biol. Chem., 267, 9505-9511.
55. Yanagishita, M. and Hascall, V.C. (1992) Cell surface heparan sulfate proteoglycans. J. Biol. Chem., 267, 9451-1992.